indazoles has been researched along with Adenoma, Prostatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcigir, ME; Bakar-Ates, F; Ekim, O; Hascicek, C; Sengel-Turk, CT | 1 |
| Andriole, GL; Bullock, TL | 1 |
1 review(s) available for indazoles and Adenoma, Prostatic
| Article | Year |
|---|---|
Emerging drug therapies for benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Antineoplastic Agents; Calcitriol; Cell Proliferation; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Indazoles; Male; Naphthalenes; Phytotherapy; Piperazines; Plant Extracts; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Receptors, Adrenergic, alpha-1; Serenoa | 2006 |
1 other study(ies) available for indazoles and Adenoma, Prostatic
| Article | Year |
|---|---|
Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model.
Topics: Animals; Apoptosis; Disease Models, Animal; Drug Compounding; Enzyme Inhibitors; Hexokinase; Indazoles; Lipids; Liver; Male; Nanomedicine; Nanoparticles; Polymers; Prostate; Prostatic Hyperplasia; Rats | 2020 |